Compass Therapeutics, Inc. (CMPX)
0.8465
-0.01
(-1.57%)
USD |
NASDAQ |
Oct 19, 13:20
Compass Therapeutics Cash from Operations (Annual) : -49.14M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -49.14M |
| December 31, 2024 | -44.86M |
| December 31, 2023 | -40.62M |
| December 31, 2022 | -34.12M |
| Date | Value |
|---|---|
| December 31, 2021 | -19.67M |
| December 31, 2020 | -26.80M |
| December 31, 2019 | -31.74M |
| December 31, 2018 | -33.68M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viking Therapeutics, Inc. | -278.68M |
| Capricor Therapeutics, Inc. | -69.81M |
| Ardelyx, Inc. | -42.48M |
| Biomea Fusion, Inc. | -70.37M |
| ARS Pharmaceuticals, Inc. | -170.87M |